A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients

Status:	Completed
Conditions:	Overactive Bladder
Therapuetic Areas:	Gastroenterology
Healthy:	No
Age Range:	18 - Any
Updated:	12/7/2018
Start Date:	January 2007
End Date:	October 2007

A 12-Week, Multicenter, Open-Label, Single-Arm Study To Evaluate The Effects Of Fesoterodine On Treatment Satisfaction And Symptom Relief In Overactive Bladder Patients.

To evaluate the effect of fesoterodine on patient satisfaction and overactive bladder (OAB)
symptom relief in OAB patients who were dissatisfied with their prior therapy with
tolterodine.

Inclusion Criteria:

- OAB patients who present with OAB symptoms(≥8 micturitions and ≥3 urgency episodes per
24 h documented in the baseline bladder diary)

- OAB patients dissatisfied with their prior therapy with tolterodine

Exclusion Criteria:

- Patients with any contraindication to fesoterodine usage, e.g., urinary retention,
gastric retention, uncontrolled narrow-angle glaucoma, or known hypersensitivity to
the drug or its ingredients.

- Patients with significant hepatic and renal disease or other significant unstable
diseases.

- OAB symptoms caused by neurological conditions, known pathologies of urinary tract,
etc.

We found this trial at

sites

A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients

Use our guide to learn which trials are right for you!

A 12-Week, Multicenter, Open-Label, Single-Arm Study To Evaluate The Effects Of Fesoterodine On Treatment Satisfaction And Symptom Relief In Overactive Bladder Patients.

Select your condition

Common Conditions

All Conditions